Federico Grossi

Overview

Federico Grossi received an average of $3M in total compensation, including $389K in salary, at Apellis Pharmaceuticals between 2018 and 2021.

201820210700K1.4M2.1M2.8M
Source: SEC filings on April 20, 2022 and April 30, 2019.

Related executives

We found eight more executives who work or worked at Apellis Pharmaceuticals.

Cedric Francois

Apellis Pharmaceuticals

Chief Executive Officer

Timothy Sullivan

Apellis Pharmaceuticals

Chief Financial Officer

Pascal Deschatelets

Apellis Pharmaceuticals

Chief Scientific Officer

Adam Townsend

Apellis Pharmaceuticals

Chief Commercial Officer

Nur Nicholson

Apellis Pharmaceuticals

Chief Technical Operations Officer

Lucia Celona

Apellis Pharmaceuticals

Former Chief People Officer

Thomas Lackner

Apellis Pharmaceuticals

Senior Vice President, Head of Europe

Lukas Scheibler

Apellis Pharmaceuticals

Chief Innovation Officer

News

You may also like

0